Under construction – not a live service

Skip to content

Frontlight Research

Institution

Massachusetts General Hospital

Boston, United StateshealthcareWebsite

Also known as: Hospital General de Massachusetts · Mass General · MGH

750running trials
373closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Not yet recruiting
Adiposity Distribution in Acute Respiratory Failure
NCT07019987· Source
Not yet recruiting
Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)
NCT07216859· Source
Not yet recruiting
Intervention to Reduce Implicit Bias in Pharmacies
NCT06487351· Source
Not yet recruiting
Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG
NCT07226830· Source
Not yet recruiting
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT07923526· Phase 2/3· Source
Not yet recruiting
Safety Study of XT-150 in Participants With ALS
NCT06704347· Phase 1· Source
Not yet recruiting
Reducing Arterial Inflammation Using Eplerenone and Statins in HIV
NCT07892664· Phase 2/3· Source
Not yet recruiting
Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer
NCT07265739· Phase 2· Source
Not yet recruiting
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
NCT07240805· Source
Not yet recruiting
Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PC
NCT07765836· Phase 2· Source
Not yet recruiting
Training on Systemic and Organ Spec. PM in PC
NCT07768917· Source
Not yet recruiting
Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization
NCT07569250· Source
Not yet recruiting
A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment
NCT07926321· Phase 2· Source
Recruiting
Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
NCT06791057· Source
Not yet recruiting
Feasibility and Acceptability of Amani
NCT07648043· Phase 1/2· Source
Not yet recruiting
Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation
NCT07729332· Phase 4· Source
Not yet recruiting
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum
NCT07569367· Source
Recruiting
Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)
NCT07665372· Source
Not yet recruiting
Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT07923591· Phase 2· Source
Not yet recruiting
LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol A
NCT07685028· Source
Not yet recruiting
A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.
NCT06458907· Source
Not yet recruiting
Inhaled Nitric Oxide in Severe Obesity
NCT06675435· Source
Not yet recruiting
The Care for America's Aging Study
NCT06021704· Source
Not yet recruiting
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated Cirrhosis
NCT07755059· Source
Not yet recruiting
Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis
NCT07520110· Phase 3· Source
Enrolling by invitation
The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab
NCT07688239· Phase 2· Source
Recruiting
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
NCT07701941· Phase 1/2· Source
Not yet recruiting
CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC
NCT07077083· Phase 2· Source
Recruiting
The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
NCT07699445· Phase 4· Source
Recruiting
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
NCT07623200· Phase 3· Source
Recruiting
Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML
NCT07355335· Phase 1· Source
Not yet recruiting
Developing Resiliency and Exercise Using AI-based Messaging
NCT07225283· Source
Not yet recruiting
Remote Monitoring in Progressive Supranuclear Palsy (PSP)
NCT04753320· Source
Recruiting
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
NCT07625215· Phase 2· Source
Recruiting
Time Restricted Eating (TRE) in Bipolar Disorder
NCT07211217· Source
Recruiting
Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD
NCT07010302· Phase 4· Source
Recruiting
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
NCT07569926· Phase 4· Source
Not yet recruiting
NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome
NCT07278492· Phase 1· Source
Recruiting
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
NCT06996652· Phase 2· Source
Recruiting
Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?
NCT07454733· Source
Not yet recruiting
Medically Tailored Meals to Reduce Ultra-processed Food Intake in Colorectal Cancer Survivors
NCT07701707· Source
Not yet recruiting
ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma
NCT07247097· Phase 2· Source
Not yet recruiting
Verapamil Effect in Cystic Fibrosis-related Dysglycemia
NCT07688070· Phase 2· Source
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087· Phase 3· Source
Enrolling by invitation
Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a)
NCT07496463· Phase 2· Source
Recruiting
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
NCT07575269· Source
Recruiting
A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer
NCT07513311· Source
Recruiting
GBPDC: Gut-Brain in PD Consortium Master Protocol
NCT07567794· Source
Recruiting
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT07719361· Phase 1· Source
Recruiting
Pridopidine Phase 3 Study in Huntington's Disease
NCT07609108· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Lung cancer57 recruiting
Colorectal cancer35 recruiting
Ovarian cancer24 recruiting
Pancreatic cancer22 recruiting
Childhood cancers21 recruiting
Heart failure20 recruiting
Prostate cancer20 recruiting
Stroke19 recruiting
Coronary artery disease16 recruiting
Gastric and esophageal cancer16 recruiting
Melanoma16 recruiting
ALS (motor neurone disease)15 recruiting
Head and neck cancer15 recruiting
Obesity15 recruiting
Alzheimer disease13 recruiting
Endometrial cancer13 recruiting
High blood pressure13 recruiting
Liver and biliary tract cancer13 recruiting
Metastatic breast cancer13 recruiting
Type 2 diabetes13 recruiting
Parkinson disease12 recruiting
Triple-negative breast cancer12 recruiting
Depression11 recruiting
Glioblastoma11 recruiting
Multiple myeloma11 recruiting
Acute myeloid leukemia9 recruiting
Atrial fibrillation9 recruiting
HIV9 recruiting
Bladder cancer8 recruiting
Cervical cancer8 recruiting
Cystic fibrosis8 recruiting
Chronic kidney disease7 recruiting
Myeloproliferative neoplasms7 recruiting
Pulmonary arterial hypertension7 recruiting
Sarcoma7 recruiting
Amyloidosis6 recruiting
Crohn's disease6 recruiting
Epilepsy6 recruiting
Idiopathic pulmonary fibrosis6 recruiting
Diffuse large B-cell lymphoma5 recruiting
Mesothelioma5 recruiting
Myasthenia gravis5 recruiting
Myelodysplastic syndromes5 recruiting
Thyroid cancer5 recruiting
Ulcerative colitis5 recruiting
Bipolar disorder4 recruiting
Follicular lymphoma4 recruiting
Kidney cancer4 recruiting
Multiple sclerosis4 recruiting
Neuromyelitis optica (NMOSD)4 recruiting
Rheumatoid arthritis4 recruiting
Chronic lymphocytic leukaemia3 recruiting
Chronic myeloid leukaemia3 recruiting
COPD3 recruiting
Lewy body dementia3 recruiting
Lupus (SLE)3 recruiting
Neuroendocrine tumours3 recruiting
Schizophrenia3 recruiting
Type 1 diabetes3 recruiting
Acute lymphoblastic leukaemia2 recruiting
Asthma2 recruiting
Autism2 recruiting
Fatty liver disease (MASLD/MASH)2 recruiting
Frontotemporal dementia2 recruiting
Huntington's disease2 recruiting
Mantle cell lymphoma2 recruiting
Sickle cell disease2 recruiting
Systemic sclerosis (scleroderma)2 recruiting
ANCA-associated vasculitis1 recruiting
Atopic dermatitis (eczema)1 recruiting
Duchenne muscular dystrophy1 recruiting
Hepatitis B1 recruiting
Hodgkin lymphoma1 recruiting
Hypertrophic cardiomyopathy1 recruiting
Long COVID and ME/CFS1 recruiting
Osteoporosis1 recruiting
Primary biliary cholangitis1 recruiting
Retinitis pigmentosa1 recruiting
Thalassaemia1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

Withdrawn
A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders
NCT05974293· Phase 2· Source
Withdrawn
Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma
NCT07283848· Phase 2· Source
Completed
Pilot Study of a Brain Health Program in Senior Centers
NCT07424443· Source
Completed
Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care
NCT07364825· Source
Withdrawn
Feasibility Study of LUM Imaging System for Pancreatic Cancer
NCT04276909· Source
Completed
Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2
NCT06182241· Source
Terminated
An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)
NCT06961344· Phase 2· Source
Recruiting
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
NCT06908928· Phase 1· Source
Completed
Data Collection for Echocardiography-Based Software Assessment
NCT07126600· Source
Completed
Innovative Automated Insulin Delivery System for Type 2 Diabetes
NCT06853990· Source
Completed
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
NCT06262113· Source
Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
NCT06690398· Phase 3· Source
Completed
Investigating the Relationship Between Glycemia and Sleep in Adults With Cystic Fibrosis-Related Diabetes
NCT06700889· Source
Completed
Sapphire 3 CTO Study
NCT06358508· Source
Completed
Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening
NCT06472869· Source
Completed
PACE CF, a 3-session Mind-body Pain Management Program for Adults With Cystic Fibrosis
NCT06606457· Source
Completed
A Phase 2b Study of Zagociguat in Patients With MELAS
NCT06402123· Phase 2· Source
Recruiting
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
NCT06445608· Source
Completed
CHW Intervention to Improve Nutrition Security of Patients With Hypertension
NCT06358417· Source
Withdrawn
Waitlist-Control Trial of Smartphone CBT for Major Depressive Disorder (MDD)
NCT04594616· Source
Completed
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
NCT06322342· Phase 2· Source
Completed
RECOVER-SLEEP: Platform Protocol
NCT06404086· Phase 2· Source
Completed
RECOVER-ENERGIZE Platform Protocol
NCT06404047· Source
Completed
Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy
NCT06387186· Phase 1· Source
Withdrawn
Immunomodulatory Effects of PCSK9 Inhibition
NCT05720156· Source
Completed
Supporting Our Caregivers In ADRD Learning (SOCIAL)
NCT06276023· Source
Completed
Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes
NCT06273124· Source
Completed
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors
NCT06208124· Phase 1/2· Source
Completed
Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect
NCT06265532· Phase 1· Source
Completed
The T1D Parent Check-In: A Preventative Intervention
NCT06160934· Source
Completed
Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)
NCT06004167· Source
Terminated
PRO1107 in Patients With Advanced Solid Tumors
NCT06171789· Phase 1/2· Source
Completed
Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial
NCT06089135· Source
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
NCT05934526· Phase 3· Source
Completed
Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
NCT06234488· Source
Completed
Esophageal Cancer Multimodal Prehabilitation Study
NCT06027515· Source
Terminated
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
NCT06097260· Phase 2· Source
Completed
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
NCT06130566· Phase 3· Source
Terminated
Study of ALE.C04 in Patients With Head and Neck Cancer
NCT06054477· Phase 1/2· Source
Completed
Dampening the Reproductive Axis With Continuous Kisspeptin
NCT05971849· Phase 1· Source
Completed
Guideline Directed Medical Therapy in Patients With Heart Failure
NCT06700213· Source
Completed
MASC: Reducing Stress for Caregivers
NCT05847153· Source
Completed
Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)
NCT06060665· Phase 3· Source
Completed
Facilitators and Barriers to the Clinical Implementation of MR-001
NCT06003790· Source
Completed
Phase 1 Study to Assess Safety and Efficacy of ANG003
NCT06052293· Phase 1· Source
Completed
Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients
NCT05195918· Phase 1· Source
Completed
Health Outcomes of Parents With Cystic Fibrosis
NCT05829694· Source
Withdrawn
Fulvestrant + Neratinib In Breast Cancer
NCT04901299· Phase 2· Source
Completed
Conditionally Increased Output (CIO) Enhanced Ultrasound System
NCT05792423· Source
Terminated
PR3-AAV Resilient Remission or PRRR
NCT05376319· Phase 2· Source

Trial sites

Conditions

Diseases this institution publishes on or runs trials for.

Alzheimer disease618 works · 25 trials
Stroke524 works · 41 trials
HIV316 works · 21 trials
Heart failure288 works · 44 trials
Obesity287 works · 28 trials
Lung cancer253 works · 146 trials
Type 2 diabetes188 works · 18 trials
Atrial fibrillation180 works · 25 trials
Melanoma180 works · 68 trials
Coronary artery disease156 works · 38 trials
Colorectal cancer136 works · 85 trials
Prostate cancer135 works · 42 trials
Depression118 works · 20 trials
Epilepsy114 works · 21 trials
Parkinson disease113 works · 23 trials
Schizophrenia111 works · 7 trials
Liver and biliary tract cancer107 works · 40 trials
Pancreatic cancer83 works · 65 trials
Chronic kidney disease80 works · 11 trials
Bipolar disorder77 works · 10 trials
Sarcoma77 works · 34 trials
Multiple sclerosis73 works · 16 trials
Asthma71 works · 6 trials
ALS (motor neurone disease)70 works · 26 trials
Ovarian cancer67 works · 64 trials
Autism63 works · 9 trials
Glioblastoma63 works · 26 trials
Tuberculosis59 works · 0 trials
Multiple myeloma58 works · 45 trials
Acute myeloid leukemia50 works · 47 trials

Institution data: ROR 002pd6e78 (CC0-1.0)Updated 10 Nov 2026

Report an error